Beijing Cancer Hospital - PPDS

Beijing 100142

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations — Running, not enrolling